A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma
Cancer Medicine · 2023-02 · 12 (4) · 5071-5087
DOI: 10.1002/cam4.5247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 26.09.2022. Verfasst von Jia Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth People's Hospital of Chengdu, Chengdu, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Glioma, the most common malignant brain tumor, leads to high recurrence rates and disabilities in patients. Pyroptosis is an inflammasomes‐induced programmed cell death in response to infection or chemotherapy. However, the role of pyroptosis in glioma has not yet been elucidated.
Methods
RNA‐seq data and clinical information of 660 gliomas and 847 samples were downloaded from the TCGA and CGGA, respectively. Then, data of 104 normal brain tissues was retrieved from the GTEx for differential expression analysis. Twelve pairs of peritumoral tissue and glioma samples were used for validation. Gene alteration status of differentially expressed pyroptosis‐related regulators in gliomas was detected in cBioPortal algorithm. Consensus clustering was employed to classify gliomas based on differentially expressed pyroptosis‐related regulators. Subsequently, a PS‐signature was constructed using LASSO‐congressional analysis for clinical application. The immune infiltration of glioma microenvironment (TME) was explored using ESTIMATE, CIBERSORT, and the other immune signatures. Results cBioPortal algorithm revealed alteration of these regulators was correlated to better prognosis of gliomas. Then, our study showed that pyroptosis‐related regulators can be used to sort out patients into two clusters with distinct prognostic outcome and immune status. Moreover, a PS‐signature for predicting the prognosis of glioma patients was developed based on the identified subtypes. The high PS‐score group showed more abundant inflammatory cell infiltration and stronger immune response, but with poorer prognosis of gliomas.
Conclusion
The findings of this study provide a therapeutic basis for future research on pyroptosis and unravel the relationship between pyroptosis and glioma prognosis. The risk signature can be utilized as a prognostic biomarker for glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Fourth People's Hospital of Chengdu, Chengdu, China.
- The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Neurosurgery, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
- Shantou University Medical College, Shantou, China.
- Department of Neurology, Shantou Central Hospital, Shantou, China.
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Shaojiong Zhou
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, J., Chen, S., Li, B., Zhou, S., & Lin, H. (2023). A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma. Cancer Medicine, 12(4), 5071-5087. https://doi.org/10.1002/cam4.5247
Vancouver
Chen J, Chen S, Li B, Zhou S, Lin H. A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma. Cancer Medicine. 2023;12(4):5071-5087. doi:10.1002/cam4.5247
BibTeX
@article{Chen2023,
author = {Chen, Jia and Chen, Shanwei and Li, Bingxian and Zhou, Shaojiong and Lin, Han},
title = {A pyroptosis‐related signature predicts prognosis and indicates immune microenvironment infiltration in glioma},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {5071--5087},
doi = {10.1002/cam4.5247}
}
EUVIMED